| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_08dd040d05991eebf38c6c403af796ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3efa3d1dabb37bdd42d2917e12cd6cc6 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2022-06-24^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8e9c5e2aaff550cfffd538fc94d5fe3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4240a65b55841b3334e523c45ec2fbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bdb48fb14ff3a9f894a8818ddde1ddb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a60ae32898eb39a3ad15b13914aeda81 |
| publicationDate |
2022-12-29^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022268209-A1 |
| titleOfInvention |
Derivative having pyrimidine-fused cyclic structure, and use thereof |
| abstract |
Disclosed are a derivative having a pyrimidine-fused cyclic structure, and the use thereof. The compound has a significant inhibitory effect on SOS1 protein activity; can be used as an SOS1 protein inhibitor; has excellent druggability; can be used to prepare drugs for treating diseases mediated by the SOS1 protein, such as cancer and pathogenic rashes; and has broad application prospects. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786528-B2 |
| priorityDate |
2021-06-24^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |